• NALUZOTAN CHEMBL209821

    Alternate Names:

    PRX-00023
    Naluzotan
    740873-06-7
    DCL000937
    11430856
    N-{3-[4-(4-CYCLOHEXYLMETHANESULFONYLAMINO-BUTYL)-PIPERAZIN-1-YL]-PHENYL}-ACETAMIDE
    N-(3-(4-(4-CYCLOHEXYLMETHANESULFONYLAMINOBUTYL)PIPERAZIN-1-YL)PHENYL)ACETAMIDE
    N-(3-(4-(4-(CYCLOHEXYLMETHYLSULFONAMIDO)BUTYL)PIPERAZIN-1-YL)PHENYL)ACETAMIDE
    L001689
    D09358
    HE384950
    AN-27536
    N-[3-[4-[4-(CYCLOHEXYLMETHYLSULFONYLAMINO)BUTYL]PIPERAZIN-1-YL]PHENYL]ACETAMIDE
    BDBM50187377
    SCHEMBL678016
    LQ54E5B4EW
    NALUZOTAN (USAN/INN)
    UNII-LQ54E5B4EW

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antidepressant,anxiolytic
    (0 More Sources)

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Trial Name PRX-00023
    Novel drug target Established target
    Mechanism of Interaction Serotonin 1a (5-HT1a) receptor agonist

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antidepressant,anxiolytic
    Drug Class small molecule
    FDA Approval not approved

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    11430856 Pubchem CId
    DCL000937 TTD Drug Id
    740873-06-7 CAS Number

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    NALUZOTAN pubchem_primary_name
    11430856 PubChem CID
    UNII-LQ54E5B4EW Drug Synonym

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: